, Tracking Stock Market Picks
Enter Symbol:
Teva Pharmaceutical Industries Limited (TEVA) [hlAlert]

up 21.89 %

BusinessWeek: Top Stock Picks for 2010

Posted on: Monday,  Feb 15, 2010  8:37 PM ET by BusinessWeek: Top Stock Picks for 2010

BusinessWeek: Top Stock Picks for 2010 rated Buy Teva Pharmaceutical Industries Limited (NYSE: TEVA) on 12/13/2009, when the stock price was
$53.49. Since then, Teva Pharmaceutical Industries Limited has gained 21.89% as of 09/01/2015's recent price of $65.20.
If you would have followed this BusinessWeek: Top Stock Picks for 2010's recommendation on TEVA, you would have gained 21.89% of your investment in 2088 days.

Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson?s disease and respiratory products. Teva?s active pharmaceutical ingredient business provides vertical integration to Teva?s own pharmaceutical production and sells to third party manufacturers. The Company?s global operations are conducted in North America, Europe, Latin America, Asia and Israel. Teva has operations in more than 60 countries, as well as 38 finished dosage pharmaceutical manufacturing sites in 17 countries, 20 generic research and development centers operating mostly within certain manufacturing sites and 20 API manufacturing sites around the world. In January 2009, Phibro Animal Health Corporation completed the acquisition of the Abic Animal Health business from the Company.

For investors, 2009 was a year when hopes of economic recovery sent a wide swath of the stock market higher. Even the market's most troubled companies had shares that doubled, tripled, or even quadrupled their prices. In 2010 the emerging rebound will surely have influence, as Wall Street bets on the direction of the economy, interest rates, and inflation. But next year investors may also benefit from some smart stockpicking. Strong individual results—especially unexpected earnings and sales growth—could help certain stocks stand out from the crowd. Bloomberg BusinessWeek asked experienced investors and market experts for their favorite stock picks of 2010. Not all the 16 stocks featured here will do well—in fact, our experts based their predictions on widely varying outlooks for 2010—but all have the potential to offer shareholders lucrative surprises next year. Click ahead for the diverse group of equities they chose. (Data from Bloomberg and Capital IQ. Sources currently own the stocks they recommend, unless otherwise noted.)
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/13/2009 4:00 PM Buy
as of 12/31/2009
1 Week down  -5.50 %
1 Month down  -1.17 %
3 Months   
1 YTD down  -1.17 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy